Tongrentang Technology (01666) announced interim results. Net profit of 249 million yuan to mother decreased by 26.43% year-on-year

According to the Zhitong Finance App, Tongrentang Technology (01666) announced interim results for the six months ended June 30, 2026. The group achieved revenue of 3,024 million yuan, a decrease of 19.1% year on year; net profit to mother was 249 million yuan, a decrease of 26.43% year on year; and earnings per share were 0.19 yuan.

During the reporting period, the Group adhered to the general business tone of steady and progressive management, focused on the main business of proprietary Chinese medicines around the working policy of “changing ideas, improving coordination, improving quality and efficiency, strengthening implementation, focusing on management, and building confidence”, and continued to promote marketing system reform and production and operation optimization. The Group's performance declined in the current period due to factors such as changes in the industry environment, adjustments in market demand, and the Group's active optimization of channel operation strategies. Facing market changes, the Group continues to promote the cultivation of core varieties, product structure optimization, and operational efficiency improvement. Various strategic initiatives have been steadily implemented, and the core business foundation has remained stable, laying the foundation for long-term sustainable development.